Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Lancet

• Publication date

  2014-08-23

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0140-6736(14)61137-5PMID 25152272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis

  2015cited by this paper
• Microbiota Present in Cystic Fibrosis Lungs as Revealed by Whole Genome Sequencing

  2014cited by this paper
• Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

  2014cited by this paper
• Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis.

  2014cited by this paper
• Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.

  2013cited by this paper
• Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes

  2013cited by this paper
• Resistance Development of Cystic Fibrosis Respiratory Pathogens When Exposed to Fosfomycin and Tobramycin Alone and in Combination under Aerobic and Anaerobic Conditions

  2013cited by this paper
• Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

  2013cited by this paper
• Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

  2013cited by this paper
• Biofilm Compared to Conventional Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

  2013cited by this paper
• Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection

  2013cited by this paper
• Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

  2013cited by this paper
• Normal mucus formation requires cAMP‐dependent HCO3− secretion and Ca2+‐mediated mucin exocytosis

  2013cited by this paper
• Ferrous Iron Is a Significant Component of Bioavailable Iron in Cystic Fibrosis Airways

  2013cited by this paper
• Tobramycin Inhalation Powder (TIP): An Efficient Treatment Strategy for the Management of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis

  2013cited by this paper
• Clinical Insights from Metagenomic Analysis of Sputum Samples from Patients with Cystic Fibrosis

  2013cited by this paper
• Sub‐lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen Pseudomonas aeruginosa

  2013cited by this paper
• Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations

  2013cited by this paper
• Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.

  2013cited by this paper
• Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

  2013cited by this paper
• Sublethal Ciprofloxacin Treatment Leads to Rapid Development of High-Level Ciprofloxacin Resistance during Long-Term Experimental Evolution of Pseudomonas aeruginosa

  2013cited by this paper
• Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation

  2013cited by this paper
• Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data

  2013cited by this paper
• Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

  2012cited by this paper
• Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

  2012cited by this paper
• Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model

  2012cited by this paper
• Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa.

  2012cited by this paper
• Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study

  2012cited by this paper
• Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung

  2012cited by this paper
• The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations

  2012cited by this paper
• Decade-long bacterial community dynamics in cystic fibrosis airways

  2012cited by this paper
• Quantitative Analysis of the Human Airway Microbial Ecology Reveals a Pervasive Signature for Cystic Fibrosis

  2012cited by this paper
• Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients.

  2012cited by this paper
• Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Stenotrophomonas maltophilia from Cystic Fibrosis Patients

  2012cited by this paper
• Treatment of lung infection in patients with cystic fibrosis: current and future strategies.

  2012cited by this paper
• Rapid detection of methicillin-resistant Staphylococcus aureus in screening samples by relative quantification between the mecA gene and the SA442 gene.

  2012cited by this paper
• Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis☆

  2012cited by this paper
• Hypoxia Increases Antibiotic Resistance in Pseudomonas aeruginosa through Altering the Composition of Multidrug Efflux Pumps

  2012cited by this paper
• Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model.

  2012cited by this paper
• Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.

  2011cited by this paper
• Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome

  2011cited by this paper
• Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection

  2011cited by this paper
• Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis

  2011cited by this paper
• Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis

  2011cited by this paper
• Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

  2011cited by this paper
• Pulmonary exacerbations in cystic fibrosis

  2011cited by this paper
• Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis.

  2011cited by this paper
• Bacteriophages and diffusion of genes encoding antimicrobial resistance in cystic fibrosis sputum microbiota.

  2011cited by this paper
• Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

  2011cited by this paper
• Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?

  2010cited by this paper
• Garlic as an inhibitor of Pseudomonas aeruginosa quorum sensing in cystic fibrosis—a pilot randomized controlled trial

  2010cited by this paper
• Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa

  2010cited by this paper
• Macrolide and Clindamycin Resistance in Streptococcus milleri Group Isolates from the Airways of Cystic Fibrosis Patients

  2010cited by this paper
• Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients

  2010cited by this paper
• Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

  2010cited by this paper
• Effect of Antibiotic Treatment on Bacteriophage Production by a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa

  2010cited by this paper
• McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients.

  2010cited by this paper
• The genus Prevotella in cystic fibrosis airways.

  2010cited by this paper
• Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing

  2010cited by this paper
• Treatment of Pulmonary Exacerbations in Adult Cystic Fibrosis Patients: A Review

  2010cited by this paper
• Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

  2010cited by this paper
• Analysis of the Bacterial Communities Present in Lungs of Patients with Cystic Fibrosis from American and British Centers

  2010cited by this paper
• β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

  2009cited by this paper
• Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

  2009cited by this paper
• Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

  2009cited by this paper
• Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).

  2009cited by this paper
• Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus

  2009cited by this paper
• Antibiotic Resistance in Pseudomonas aeruginosa Strains with Increased Mutation Frequency Due to Inactivation of the DNA Oxidative Repair System

  2009cited by this paper
• Pulmonary Perspective Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations

  2009cited by this paper
• Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage

  2009cited by this paper
• Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

  2008cited by this paper
• Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients

  2008cited by this paper
• The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients

  2008cited by this paper
• Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections

  2008cited by this paper
• Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis

  2008cited by this paper
• Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

  2007cited by this paper
• Maintenance Azithromycin Treatment in Pediatric Patients With Cystic Fibrosis: Long-Term Outcomes Related to Macrolide Resistance and Pulmonary Function

  2007cited by this paper
• Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

  2007cited by this paper
• Sputum antibiotic concentrations: Implications for treatment of cystic fibrosis lung infection

  2007cited by this paper
• Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.

  2007cited by this paper
• Cystic fibrosis mortality and survival in the UK: 1947–2003

  2007cited by this paper
• Differences in Potential for Selection of Clindamycin-Resistant Mutants Between Inducible erm(A) and erm(C) Staphylococcus aureus Genes

  2007cited by this paper
• Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes

  2007cited by this paper
• Outcomes of Adults with Cystic Fibrosis Infected with Antibiotic-Resistant Pseudomonas aeruginosa

  2006cited by this paper
• Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.

  2006cited by this paper
• Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

  2005cited by this paper
• Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

  2005cited by this paper
• Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.

  2005cited by this paper
• Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms

  2005cited by this paper
• Aminoglycoside antibiotics induce bacterial biofilm formation

  2005cited by this paper
• Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.

  2005cited by this paper
• Early intervention and prevention of lung disease in cystic fibrosis: a European consensus.

  2004cited by this paper
• Stratified Growth in Pseudomonas aeruginosa Biofilms

  2004cited by this paper
• Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

  2004cited by this paper
• Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling

  2004cited by this paper
• Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling

  2003cited by this paper
• Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.

  2003cited by this paper
• Methicillin‐resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol

  2003cited by this paper
• Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

  2002cited by this paper
• Effects of β-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis

  2001cited by this paper

• Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects

  2025cites this paper
• Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis

  2025cites this paper
• Dual Antibiotics‐Based pH‐Responsive Carrier‐Free Nanodrug against Bacterial Mixed Infection for Accelerated Wound Healing

  2025cites this paper
• Antimicrobial resistance pattern due to oxygen gap at high altitudes

  2025cites this paper
• The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers—A Population-Based Study

  2025cites this paper
• Planktonic Aggregation Enhances Antibiotic Tolerance in Non-MDR Acinetobacter baumannii

  2025cites this paper
• Genomic insights and phenotypic characterisation of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung.

  2025cites this paper
• From Microbial Ecology to Clinical Challenges: The Respiratory Microbiome’s Role in Antibiotic Resistance

  2025influential citation
• The dissemination, health risks, and mitigation approaches of antibiotic resistance genes in the gut microbiome

  2025cites this paper
• Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis‐Related Pulmonary Exacerbations

  2025cites this paper
• Dual oxygen supply system of carbon dot-loaded microbubbles with acoustic cavitation for enhanced sonodynamic therapy in diabetic wound healing.

  2025cites this paper
• Wake biofilm up to enhance suicidal uptake of gallium for chronic lung infection treatment.

  2024cites this paper
• Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on the oropharyngeal metagenome in adolescents with cystic fibrosis.

  2024cites this paper
• Discovery of novel dihydropyrrolidone-thiadiazole compound crosstalk between the YycG/F two-component regulatory pathway and cell membrane homeostasis to combat methicillin-resistant Staphylococcus aureus.

  2024cites this paper
• Stenotrophomonas maltophilia: The Landscape in Critically Ill Patients and Optimising Management Approaches

  2024cites this paper
• DHTPY-Cu@ZOL-Enhanced Photodynamic Therapy: A Strategic Platform for Advanced Treatment of Drug-Resistant Bacterial Wound Infections

  2024cites this paper
• Bibliometric analysis of intestinal microbiota and lung diseases

  2024cites this paper
• Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?

  2023cites this paper
• Biofilm formation: mechanistic insights and therapeutic targets

  2023cites this paper
• Antibiotic resistance, bacterial transmission and improved prediction of bacterial infection in patients with antibody deficiency

  2023cites this paper
• A cooperativity between virus and bacteria during respiratory infections

  2023cites this paper
• Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis

  2023cites this paper
• Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients

  2023cites this paper
• Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis

  2023cites this paper
• Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance

  2023cites this paper
• Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens

  2023cites this paper
• Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs

  2022cites this paper
• Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation

  2022cites this paper
• Ocular Rosacea microBiome Study (ORBS)—sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial

  2022cites this paper
• Rapid separation of bacteria from primary nasal samples using inertial microfluidics.

  2022cites this paper
• New concepts in antimicrobial resistance in cystic fibrosis respiratory infections.

  2022cites this paper
• Opportunistic Pathogens in Cystic Fibrosis: Epidemiology and Pathogenesis of Lung Infection.

  2022cites this paper
• Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation

  2022cites this paper
• Ruthenium(II) Polypyridyl Complexes for Antimicrobial Photodynamic Therapy: Prospects for Application in Cystic Fibrosis Lung Airways

  2022influential citation
• Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species

  2022cites this paper
• Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome

  2022cites this paper
• A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients

  2022cites this paper
• N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms Formed by Clinical Strains of Pseudomonas aeruginosa Isolated from Sputum of Cystic Fibrosis Patients

  2022cites this paper
• The rapid reduction of infection-related visits and antibiotic use among people with cystic fibrosis after starting Elexacaftor-Tezacaftor-Ivacaftor.

  2022cites this paper
• Genomic diversity and antimicrobial resistance of Prevotella species isolated from chronic lung disease airways

  2022cites this paper
• Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission

  2021cites this paper
• Genomic diversity and antimicrobial resistance of Prevotella spp. isolated from chronic lung disease airways

  2021cites this paper
• Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function

  2021cites this paper
• Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?

  2021influential citation
• Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review.

  2021cites this paper
• Nanoparticles: Powerful Tool to Mitigate Antibiotic Resistance

  2021cites this paper
• Green synthesized Silver Nanoparticles as Silver Lining in Antimicrobial Resistance: A Review.

  2021cites this paper
• Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives

  2021cites this paper
• Spirulina phenolic compounds: natural food additives with antimicrobial properties

  2021cites this paper
• The Effects of Sub-inhibitory Antibiotic Concentrations on Pseudomonas aeruginosa: Reduced Susceptibility Due to Mutations

  2021cites this paper
• A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

  2021cites this paper
• Emerging non-pulmonary complications for adults with cystic fibrosis.

  2021cites this paper
• Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa.

  2021cites this paper
• The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi

  2020cites this paper
• Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria.

  2020cites this paper
• PARGT: a software tool for predicting antimicrobial resistance in bacteria

  2020cites this paper
• Cystic fibrosis – Ten promising therapeutic approaches in the current era of care

  2020cites this paper
• The future of cystic fibrosis care: a global perspective.

  2020cites this paper
• Myxobacteria-Derived Outer Membrane Vesicles: Potential Applicability Against Intracellular Infections

  2020cites this paper
• Pseudomonas aeruginosa Can Degrade Interferon λ, Thereby Repressing the Antiviral Response of Bronchial Epithelial Cells

  2020cites this paper
• Gram negative infections in cystic fibrosis: a review of preventative and treatment options

  2020influential citation
• Quantitative real-time PCR assay for the rapid identification of the intrinsically multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia

  2019cites this paper
• Airway microenvironment alterations and pathogen growth in cystic fibrosis

  2019cites this paper
• Anaerobes in cystic fibrosis patients’ airways

  2019influential citation
• Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases

  2019cites this paper
• Rapid molecular detection of macrolide resistance

  2019cites this paper
• Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life

  2019cites this paper
• Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients

  2019cites this paper
• Magnesium-doped zinc oxide nanoparticles alter biofilm formation of Proteus mirabilis.

  2019cites this paper
• Quantitative real-time PCR assay for the rapid identification of the multidrug-resistant bacterial pathogen Stenotrophomonas maltophilia

  2019cites this paper
• Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture

  2019cites this paper
• Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes

  2019cites this paper
• Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics

  2019cites this paper
• Candida albicans enhances meropenem tolerance of Pseudomonas aeruginosa in a dual-species biofilm

  2019cites this paper
• Microbiology of Cystic Fibrosis Airway Disease

  2019cites this paper
• Synthetic Polymyxin-based Peptides Against Multidrug Resistant Bacteria: A Therapeutic Option

  2019cites this paper
• Toxicidad medicamentosa por linezolid en un paciente con infección por Mycobacterium abscessus y fibrosis quística: reporte de un caso y revisión del tema

  2019cites this paper
• Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes.

  2019cites this paper
• Defining antimicrobial resistance in cystic fibrosis.

  2018cites this paper
• Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity

  2018influential citation
• Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum

  2018cites this paper
• Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy

  2018cites this paper
• Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens

  2018cites this paper
• Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study

  2018cites this paper
• Quantitative assessment of individual populations within polymicrobial biofilms

  2018cites this paper
• Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces

  2018cites this paper
• Chronic infection sustained by a Pseudomonas aeruginosa High-Risk clone producing the VIM-1 metallo-β-lactamase in a cystic fibrosis patient after lung transplantation.

  2018cites this paper
• Diversification of Pseudomonas aeruginosa within the cystic fibrosis lung and its effects on antibiotic resistance.

  2018cites this paper
• Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity

  2018influential citation
• Design of novel F-ATP synthase inhibitors of mycobacterium tuberculosis

  2018cites this paper
• Biogenic and Biomimetic Carriers as Versatile Transporters To Treat Infections.

  2018cites this paper
• Anaerobic bacteria cultured from CF airways correlate to milder disease-a multisite study

  2018cites this paper
• Symposium Summaries

  2018cites this paper
• Human microbiomes and antibiotic resistance

  2018cites this paper
• Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract

  2018cites this paper
• Non-coding RNA in cystic fibrosis.

  2018cites this paper
• Screening, purification and characterisation of anti-pseudomonas aeruginosa compounds produced by endophytic fungi from Kigelia Africana.

  2018influential citation
• Enzymatic Transition States and Drug Design.

  2018cites this paper
• A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness

  2017cites this paper
• Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa

  2017cites this paper